Document Detail


Tel/PDGFRbeta inhibits self-renewal and directs myelomonocytic differentiation of ES cells.
MedLine Citation:
PMID:  18355917     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The leukemic oncogene Tel/PDGFRbeta, was inducibly expressed in embryonic stem (ES) cells and the phenotypic and molecular changes occurring during hematopoietic differentiation investigated. Expression of Tel/PDGFRbeta resulted in an inability of ES cells to self-renew and caused a significant increase in myelopoiesis with a corresponding decrease in erythropoiesis. Analysis of gene expression patterns indicated a dramatic alteration in the levels of genes associated with self-renewal and differentiation, especially myelomonocytic genes in Tel/PDGFRbeta-expressing cells. This study indicates Tel/PDGFRbeta drives myelopoiesis by altering expression of genes involved in hematopoiesis and demonstrates the potential of this stem cell system to study oncogene-induced pathogenesis.
Authors:
E Dobbin; P M Corrigan; C P Walsh; M J Welham; R W Freeburn; H Wheadon
Related Documents :
3258537 - Interleukin-5 is at 5q31 and is deleted in the 5q- syndrome.
10597047 - Functional characterization of tel/aml1 fusion protein in the regulation of human cr1 g...
9373237 - Fusion of the platelet-derived growth factor receptor beta to a novel gene cev14 in acu...
9292517 - Mutations in the murine fitness 1 gene result in defective hematopoiesis.
9651357 - Isolation and characterization of page-1 and gage-7. new genes expressed in the lncap p...
18511457 - Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic appro...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-03-19
Journal Detail:
Title:  Leukemia research     Volume:  32     ISSN:  0145-2126     ISO Abbreviation:  Leuk. Res.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-06-13     Completed Date:  2008-08-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7706787     Medline TA:  Leuk Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  1554-64     Citation Subset:  IM    
Affiliation:
Biomedical Sciences Research Institute, University of Ulster, Cromore Road, Coleraine, Northern Ireland, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Differentiation
Cell Proliferation
Cell Survival
Cells, Cultured
Embryonic Stem Cells / cytology,  metabolism*
Gene Expression Regulation
Hematopoiesis / genetics
Leukemia Inhibitory Factor / pharmacology
Mice
Myeloid Cells / cytology
Myelopoiesis*
Oncogene Proteins, Fusion / metabolism*
Grant Support
ID/Acronym/Agency:
//Medical Research Council
Chemical
Reg. No./Substance:
0/Leukemia Inhibitory Factor; 0/Oncogene Proteins, Fusion; 0/TEL-PDGFRbeta fusion protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dependence of regulatory volume decrease on transient receptor potential vanilloid 4 (TRPV4) express...
Next Document:  Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leuke...